Search Results - "VAN DER SCHOOT, C. E"

Analysis of minimal residual disease by Ig TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data by VAN DER VELDEN, V. H. J, CAZZANIGA, G, CAYUELA, J. M, TRKA, J, ECKERT, C, FORONI, L, ZUR STADT, U, BELDJORD, K, RAFF, T, VAN DER SCHOOT, C. E, VAN DONGEN, J. J. M, SCHRAUDER, A, HANCOCK, J, BADER, P, PANZER-GRUMAYER, E. R, FLOHR, T, SUTTON, R, CAVE, H, MADSEN, H. O

“…Most modern treatment protocols for acute lymphoblastic leukaemia (ALL) include the analysis of minimal residual disease (MRD). To ensure comparable MRD…”
Get full text

Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review by Kamphuis, MM, Paridaans, N, Porcelijn, L, De Haas, M, van der Schoot, CE, Brand, A, Bonsel, GJ, Oepkes, D

“…Please cite this paper as: Kamphuis M, Paridaans N, Porcelijn L, De Haas M, van der Schoot C, Brand A, Bonsel G, Oepkes D. Screening in pregnancy for fetal or…”
Get full text

Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia by VERHAGEN, O. J. H. M, WILLEMSE, M. J, BREUNIS, W. B, WIJKHUIJS, A. J. M, JACOBS, D. C. H, JOOSTEN, S. A, VAN WERING, E. R, VAN DONGEN, J. J. M, VAN DER SCHOOT, C. E

“…Large-scale clinical studies on detection of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) have shown that quantification of MRD levels…”
Get full text

Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemia by Denys, B, van der Sluijs-Gelling, A J, Homburg, C, van der Schoot, C E, de Haas, V, Philippé, J, Pieters, R, van Dongen, J J M, van der Velden, V H J

“…Most current treatment protocols for acute lymphoblastic leukemia (ALL) include minimal residual disease (MRD) diagnostics, generally based on PCR analysis of…”
Get full text

Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7‐year clinical experience by Scheffer, PG, van der Schoot, CE, Page‐Christiaens, GCML, de Haas, M

“…Please cite this paper as: Scheffer P, van der Schoot C, Page‐Christiaens G, de Haas M. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in…”
Get full text

Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR by VAN DER VELDEN, V. H. J, WILLEMSE, M. J, VAN DER SCHOOT, C. E, HÄHLEN, K, VAN WERING, E. R, VAN DONGEN, J. J. M

“…Immunoglobulin gene rearrangements are used as PCR targets for detection of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL). We…”
Get full text

Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia by Waanders, E, van der Velden, V H J, van der Schoot, C E, van Leeuwen, F N, van Reijmersdal, S V, de Haas, V, Veerman, A J, van Kessel, A Geurts, Hoogerbrugge, P M, Kuiper, R P, van Dongen, J J M

“…Response to therapy as determined by minimal residual disease (MRD) is currently used for stratification in treatment protocols for pediatric acute…”
Get full text

Migratory behavior of leukemic cells from acute myeloid leukemia patients by VOERMANS, C, VAN HEESE, W. P. M, DE JONG, I, GERRITSEN, W. R, VAN DER SCHOOT, C. E

“…The chemokine stromal cell-derived factor-1 (SDF-1) and its receptor CXCR-4 contribute to stem cell homing and may play a role in the trafficking of leukemic…”
Get full text

Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands by Koelewijn, J.M., Vrijkotte, T.G.M., Van Der Schoot, C.E., Bonsel, G.J., De Haas, M.

“…BACKGROUND: Hemolytic disease of the fetus and newborn (HDFN) is a severe disease, resulting from maternal red cell (RBC) alloantibodies directed against fetal…”
Get full text

Noninvasive fetal genotyping of human platelet antigen‐1a by Scheffer, PG, Ait Soussan, A, Verhagen, OJHM, Page‐Christiaens, GCML, Oepkes, D, de Haas, M, van der Schoot, CE

“…Please cite this paper as: Scheffer P, Ait Soussan A, Verhagen O, Page‐Christiaens G, Oepkes D, de Haas M, van der Schoot C. Noninvasive fetal genotyping of…”
Get full text

Detection of fetal RHD-specific sequences in maternal plasma by Faas, BHW, Beuling, EA, Christiaens, GC ML, von dem Borne, AEG Kr, van der School, CE

“…Faas et al show that fetal RHD genotyping can be done from maternal plasma…”
Get full text

The prognostic value of fast molecular response of marrow disease in patients aged over 1 year with stage 4 neuroblastoma by Stutterheim, J, Zappeij-Kannegieter, L, Versteeg, R, Caron, H.N, van der Schoot, C.E, Tytgat, G.A.M

“…Abstract Background Quantitative real-time (q)PCR for detection of minimal residual disease (MRD) in children with neuroblastoma (NB) can evaluate molecular…”
Get full text

Risk factors for RhD immunisation despite antenatal and postnatal anti‐D prophylaxis by Koelewijn, JM, de Haas, M, Vrijkotte, TGM, van der Schoot, CE, Bonsel, GJ

“…Objective  To identify risk factors for Rhesus D (RhD) immunisation in pregnancy, despite adequate antenatal and postnatal anti‐D prophylaxis in the previous…”
Get full text

Predicting anti-RhD titers in donors: Boostering response and decline rates are personal by de Vos, Anneke S, van der Schoot, Ellen C E, Rizopoulos, Dimitris, Janssen, Mart P

“…Anti-RhD immunised donors provide anti-RhD immunoglobulins used for the prevention of rhesus disease. These donors are periodically hyper-immunised (boostered)…”
Get full text

Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy by DE HAAS, V, VERHAGEN, O. J. H. M, VON DEM BORNE, A. E. G. Kr, KROES, W, VAN DEN BERG, H, VAN DER SCHOOT, C. E

“…Antigen receptor gene rearrangements are applied for the PCR-based minimal residual disease (MRD) detection in acute lymphoblastic leukemia (ALL). It is known…”
Get full text

Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences by Waanders, E, Scheijen, B, Jongmans, M C J, Venselaar, H, van Reijmersdal, S V, van Dijk, A H A, Pastorczak, A, Weren, R D A, van der Schoot, C E, van de Vorst, M, Sonneveld, E, Hoogerbrugge, N, van der Velden, V H J, Gruhn, B, Hoogerbrugge, P M, van Dongen, J J M, Geurts van Kessel, A, van Leeuwen, F N, Kuiper, R P

“…The contribution of genetic predisposing factors to the development of pediatric acute lymphoblastic leukemia (ALL), the most frequently diagnosed cancer in…”
Get full text

Immortalisation of human bone marrow endothelial cells: characterisation of new cell lines by ROOD, P. M. L, CALAFAT, J, VON DEM BORNE, A. E. G. K, GERRITSEN, W. R, VAN DER SCHOOT, C. E

“…Background Adhesion of haematopoietic progenitor cells (HPC) to human bone marrow endothelial cells (HBMEC) plays a key role in homing of HPC to bone marrow…”
Get full text

Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes by PONGERS-WILLEMSE, M. J, VERHAGEN, O. J. H. M, TIBBE, G. J. M, WIJKHUIJS, A. J. M, DE HAAS, V, ROOVERS, E, VAN DER SCHOOT, C. E, VAN DONGEN, J. J. M

“…Analysis of minimal residual disease (MRD) can predict outcome in acute lymphoblastic leukemia (ALL). A large prospective study in childhood ALL has shown that…”
Get full text

Acute Leukemias of Different Lineages Have Similar MLL Gene Fusions Encoding Related Chimeric Proteins Resulting from Chromosomal Translocation by Corral, J., Forster, A., Thompson, S., Lampert, F., Kaneko, Y., Slater, R., Kroes, W. G., van der Schoot, C. E., W.-D. Ludwig, Karpas, A., Pocock, C., Cotter, F., Rabbitts, T. H.

“…The MLL gene, on human chromosome 11q23, undergoes chromosomal translocation in acute leukemias, resulting in gene fusion with AF4 (chromosome 4) and ENL…”
Get full text

Report of the First International Workshop on molecular blood group genotyping by Daniels, G., Van Der Schoot, C. E., Olsson, M. L.

“…The use of molecular genetic technology for blood group typing is becoming routine procedure in many reference laboratories worldwide. A First International…”
Get full text